Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Ha ha! Let’s you and me ride the Leronlimab downhill!
The Big Leronlimab Wheelee downhill is starting. Who's right....
Beautiful!
I agree. I have plenty though - bought at 10, 15, 20, and 30 cents
I, absolutely, love these dumb questions - like mj - ask the 1966 population. I know tons of people using and they're okay - 50+ years later.
comprehension or not - we're the only two here in MRMD
That's why you are responding to me...
I’ll try. But my reading comprehension gets in the way.
You know all (ALL) about risk, so it’s basically academic at this point. All in or flushed out.
Within six months, you win or you and your pals were woefully mistaken.
Can’t wait for the downhill on that rollercoaster ride.
Which one is it:
1. products given away free, typically for promotional purposes.
"I'll be showing you the best of the schwag I get my hands on each day"
2. marijuana, typically of a low grade.
"even potheads couldn't smoke that schwag"
Listen on the Wow part. Everybody makes mistakes.
Some believe they can influence share price movement by words. And some do by writing articles published to the broader public (not on message boards) even if the articles are factually inaccurate. It's impossible for any intellectual doing diligence to truly believe CYDY will not be successful and grow exponentially into the foreseeable future! Nothing anyone could write could convince me otherwise. But many play the perceived or potential market reactions. NOTHING to do with the company at all.
Why don't you tell us?
What about this prediction?
Leronlimab has been ahead of its time - it is like the Edison bulb.
The only reason that we had to wait to implement the Edison bulb was because the infrastructure was not there.
Build out a remedy using Leronlimab…
We can only predict. We are not part of management.
I would rather predict and show my support of the company while
slam
And keep slamming.
It looks to me that the investors that remain are here till the end
But I’m not giving you a nickel.
Watch your prediction too…
Fantastic!!
These last two are the real deal for a busting MAB, as in Leronlimab:
1. Leronlimab attacks 2 new things, a) Tumor-promoting inflammation and b) Avoiding immune destruction.
2. CCR5 blockade with Leronlimab reduces inflammation and keeps the immune system fully charged so that tumor cells don't fool the army, navy, air force or marines. Nothing gets by the militia when Leronlimab is on board. But, Leronlimab does all its work in stealth. It does not explode bombs to make itself known. It kills its target by suffocation.
A few more for Monday morning - regarding our favorite Mab for Leronlimab:
7. The strongest binding affinity to CCR5 is Leronlimab. Therefore, Leronlimab has MINIMAL competition. Too many other drugs have side effects.
8. 700 mg Leronlimab in Combination with Carboplatin is WELL tolerated and that combination trial currently IS being PLANNED.
Here's 4, 5, 6:
1. Leronlimab reduces cancer metastasis and reduces the tumor.
2. Leronlimab prevents the development of blood supply to the tumor.
3. Leronlimab encourages the army, recruits the Navy, enlists the air force and marines into an anti-inflammatory war against the tumor which is passive in nature. It starves the tumor, it suffocates the tumor, it extinguishes the tumor and prevents it from spreading. No inflammation.
I think someone is twisting my arm. Here is number 3:
these statements are supported by data. In layman's terms, Leronlimab turns the soldiers that suppress the army into soldiers that attack the cancer.
Here the researcher, specialist, physician reiterates:
And finally, the CCL5 suppresses also cytotoxic T-Cells that I mentioned, hence, promotes the growth of Tregs regulatory cells and TH responses, which means it suppresses the immune system. And there you go with leronlimab binding to the CCR5 across this breast cancer cell and cell lines and up to almost, not quite, 100% efficiency.
I am not making up this beautiful language. I am copying verbatim the DATA!
Just in case there are new investors who are trying to decipher exactly what Leronlimab does, here is a punch list with ten separate items. I'll post the first two now and then over the next day continue to add to the list.
1. Some soldiers of the white blood cell army improperly function. Instead of attacking cancer, they actually suppress the army, thereby allowing the cancer to live.
2. The objective is to get the immune system to work again. And it is accomplished by clearing the obstacles out of the way so the immune system can do its job.
Simple description but the human body is very complex. Stay tuned.
JohnCM: Have not heard from you in a loooong time! Glad you're back and buying CWEB.
Tell that to our buddy who has 6 gears in his car...
How about shorting? Do you think nobody is shorting this stock? If you disagree, you don't know anything about the current stock market. Shorter's delight.
The way the three in the cab described - a diesel truck has a ton of gears that one has to shift up and down. The electric truck by Nikola has a forward and backward gear. How's that?
Very quiet and only one gear!
MOST MJ stocks down today.
Whatever WISE WQLF!
If I may reiterate the current environment of all cannabis stocks. They are down, significantly.
Last year at this time, Trulieve was $26 - now about $5.
Curaleaf, Tilray - you name it. Jushi was $6, now $.46!
Charlotte's Web was about $1.42 now $.30 cents. Charlotte's Web is doing better than
Jushi.
Cresco was $9 now $1.66!
Plenty of names to buy out but I doubt any will be sold. Compression and shorting are upon us until the FEDS declassify and Congress passes the Safe Banking Act.
Just a year ago this stock was in the dollar range....
I think they all know that now...
The struggling fledgling company always has problems. It has to get diluted. If you listen to the CEO's last interview, he says pretty much the same. That's why they had to sell the European market.
Okay so I watched it and Whoa....
The ACT convention of BVEV and FCEV big rigs and trucks was last week. Anyway....
Nikola has built both types of trucks but the FCEV gets 500 miles to the tank and takes 20 minutes to refuel while the EV gets 300 miles to the tank and take 90 minutes to refuel....
Also some analysts are making a big deal that Nikola pulled out of the European market and concentrating solely on the North American market. Nikola sold their business to Iveco, their competitor in Europe but.... but... they have signed a strategic deal with Iveco for parts and other things.
Smart to concentrate on North America where no one else is right now. First mover advantage. I am buying more shares this morning...
Anyone look at the Nikola, youtube video last night? The ACT convention of BVEV and FCEV big rigs and trucks was last week. Anyway....
Nikola has built both types of trucks but the FCEV gets 500 miles to the tank and takes 20 minutes to refuel while the EV gets 300 miles to the tank and take 90 minutes to refuel....
Fumbler: You do realize that this article was published 16 months ago on January 10, 2022! Like really old news in the world of biotech!
How many votes do they need to pass #5?
I'm in - all in with a YES vote for #5.
By the way, this is not an A.I. generated video. Melon Toy is real. The name is unusual but she is a Covid victim.
Plug is down $1.28. Crazy…